Digital Biomarkers of Ulcerative Colitis Flare

溃疡性结肠炎发作的数字生物标志物

基本信息

  • 批准号:
    10652540
  • 负责人:
  • 金额:
    $ 16.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

This project will evaluate longitudinally collected physiological metrics, with a focus on autonomic nervous system function (heart rate variability [HRV]), using wearable devices. It will investigate the ability of these physiological metrics to identify and predict symptomatic ulcerative colitis (UC) flares. It will explore the modifiability of these metrics through a HRV directed biofeedback intervention and its impact on UC symptoms. Candidate: The primary objective of this application is to support the development of Dr. Robert Hirten into an independent patient-oriented researcher in the field of digital health and inflammatory bowel disease (IBD) research. Dr. Hirten’s career goal is to be an independent researcher and leader in leveraging the dense physiological data acquired through novel wearable technologies in IBD research. Dr. Hirten’s proposed training activities are in five areas: (1) Advanced statistical methodology, (2) Digital health, (3) Clinical trial design, (4) Behavioral intervention science, (5) Career development. To achieve these goals Dr. Hirten has assembled a mentorship team led by Dr. Bruce Sands, Chief of Gastroenterology at The Mount Sinai Hospital who has expertise in longitudinal and clinical trial research in IBD. Environment: The Icahn School of Medicine at Mount Sinai has a strong tradition of research and is a top 20 medical school in NIH funding. The Mount Sinai Division of Gastroenterology is a top 10 division in the country by US News and World Report and is a leader in IBD research and clinical care. The Hasso Plattner Institute for Digital Health at Mount Sinai is an international institute with expertise in data science, biomedical and digital engineering. Research: UC is a chronic inflammatory disease affecting the colon with symptomatic flares characterized by diarrhea, blood per rectum and abdominal pain. Flares are frequent, occurring in at least 30% of patients per year, and are associated with morbidity and impaired quality of life. Current methods to identify and predict flare are suboptimal and limited. If flares can be identified earlier and predicted strategies for mitigation or prevent could be instituted. Advances in digital and wearable technology allow for collection of continuous, non-invasive physiological parameters potentially linked with disease activity. Therefore, our specific aims are to (1) To determine the association of physiological metrics, including HRV, with symptomatic flare in UC, (2) To assess the predictive ability of physiological metrics, with a focus on HRV, for the development of symptomatic flare in UC, (3) Determine the feasibility, acceptability, and effect size of a HRV biofeedback intervention in subjects with symptomatic UC. To accomplish this we will perform a longitudinal cohort study enrolling 160 subjects with UC in remission and follow them for 12 months or until flare, collecting physiological indices from a wearable device (Apple Watch) and survey metrics from a smart phone application. In addition, we will perform a HRV directed biofeedback intervention in 23 subjects with UC and symptomatic flare. The general approach and skills acquired during this award can be applied to future R01 grants aimed at building upon the findings from this work.
本项目将评估纵向收集的生理指标,重点是自主神经

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis.
  • DOI:
    10.1002/ajim.23313
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Sacks HS;Smirnoff M;Carson D;Cooney ML;Shapiro MZ;Hahn CJ;Dasaro CR;Crowson C;Tassiulas I;Hirten RP;Cohen BL;Haber RS;Davies TF;Simpson DM;Crane MA;Harrison DJ;Luft BJ;Moline JM;Udasin IG;Todd AC;Sloan NL;Teitelbaum SL
  • 通讯作者:
    Teitelbaum SL
Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable device.
  • DOI:
    10.1038/s41598-024-53522-1
  • 发表时间:
    2024-02-03
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
  • 通讯作者:
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
IBD 的当前趋势 - 粘膜生物标志物的开发和新型微创可恢复采样系统。
  • DOI:
    10.1093/ibd/izab179
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Yau,YunkiY;Wasinger,ValerieC;Hirten,RobertP;Chuang,Emil;Huntsman,Merodean;Stylli,Jack;Shimizu,Jeff;Yajnik,Vijay;Smith,Jeffrey;Lee,ShaoyingN;Singh,Sharat;Wahl,Christopher;Leong,RupertW;Sands,BruceE
  • 通讯作者:
    Sands,BruceE
Impact of Care in an Interdisciplinary Inflammatory Bowel Disease Specialty Clinic on Outcomes in Patients Insured with Medicaid.
跨学科炎症性肠病专科诊所的护理对医疗补助投保患者的结果的影响。
  • DOI:
    10.1097/mcg.0000000000001769
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Wang,ChristinaP;Zylberberg,HaleyM;Borman,ZacharyA;Engelman,Sally;Yanes,Ricardo;Hirten,RobertP;Sands,BruceE;Cohen,BenjaminL;Ungaro,RyanC;Rao,BhavanaB
  • 通讯作者:
    Rao,BhavanaB
Factors Associated With Longitudinal Psychological and Physiological Stress in Health Care Workers During the COVID-19 Pandemic: Observational Study Using Apple Watch Data.
  • DOI:
    10.2196/31295
  • 发表时间:
    2021-09-13
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Hirten RP;Danieletto M;Tomalin L;Choi KH;Zweig M;Golden E;Kaur S;Helmus D;Biello A;Pyzik R;Calcagno C;Freeman R;Sands BE;Charney D;Bottinger EP;Murrough JW;Keefer L;Suarez-Farinas M;Nadkarni GN;Fayad ZA
  • 通讯作者:
    Fayad ZA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Hirten其他文献

Robert Hirten的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Hirten', 18)}}的其他基金

Digital Biomarkers of Ulcerative Colitis Flare
溃疡性结肠炎发作的数字生物标志物
  • 批准号:
    10283677
  • 财政年份:
    2021
  • 资助金额:
    $ 16.25万
  • 项目类别:
Digital Biomarkers of Ulcerative Colitis Flare
溃疡性结肠炎发作的数字生物标志物
  • 批准号:
    10471362
  • 财政年份:
    2021
  • 资助金额:
    $ 16.25万
  • 项目类别:

相似海外基金

Disrupted sleep architecture in adolescents with functional abdominal pain disorders
患有功能性腹痛疾病的青少年的睡眠结构被破坏
  • 批准号:
    10641146
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
Development and Testing of an Intervention to Facilitate Shared Decision-Making in Pediatric Patients with Abdominal Pain Presenting to the Community Emergency Department Setting
开发和测试一种干预措施,以促进社区急诊科就诊的腹痛儿科患者共同决策
  • 批准号:
    10723374
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
Abdominal Pain in Older Patients in Emergency Departments
急诊科老年患者的腹痛
  • 批准号:
    10739136
  • 财政年份:
    2023
  • 资助金额:
    $ 16.25万
  • 项目类别:
Evaluation of abdominal pain after mucosal healing in patients with inflammatory bowel disease -comprehensive analysis of HPA axis-
炎症性肠病患者黏膜愈合后腹痛评价-HPA轴综合分析-
  • 批准号:
    22K16013
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
  • 批准号:
    10387725
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain
针对有功能性腹痛风险的幼儿进行基于互联网的预防干预的随机对照试验
  • 批准号:
    10608073
  • 财政年份:
    2022
  • 资助金额:
    $ 16.25万
  • 项目类别:
Novel microbial driven histamine pathways underlying chronic abdominal pain
慢性腹痛背后的新型微生物驱动组胺途径
  • 批准号:
    453255
  • 财政年份:
    2021
  • 资助金额:
    $ 16.25万
  • 项目类别:
    Operating Grants
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10619029
  • 财政年份:
    2020
  • 资助金额:
    $ 16.25万
  • 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10045379
  • 财政年份:
    2020
  • 资助金额:
    $ 16.25万
  • 项目类别:
Home-based transcutaneous electrical acustimulation for abdominal pain
家庭经皮电针治疗腹痛
  • 批准号:
    10685484
  • 财政年份:
    2020
  • 资助金额:
    $ 16.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了